| Treatment: Treatments are directed at
| |
| | of interference by maternal antibody. To
|
| limiting secondary bacterial invasion,
| |
| | overcome this barrier, pups are
|
| supporting the fluid balance and overall
| |
| | vaccinated with MLV vaccine when 6 wk old
|
| well-being of the dog, and controlling
| |
| | and at 2-to 4-wk intervals until 16 wk
|
| nervous manifestations. Antibiotics,
| |
| | old. Measles virus induces immunity to
|
| electrolyte solutions, protein
| |
| | canine distemper virus in the presence of
|
| hydrolysates, dietary supplements,
| |
| | relatively greater levels of maternal
|
| antipyretics, nasal preparations,
| |
| | distemper antibody. An MLV measles
|
| analgesics, and anticonvulsants are used.
| |
| | vaccine and a combination of MLV measles
|
| No one treatment is specific or uniformly
| |
| | and MLV canine distemper vaccine are
|
| successful. Dogs may recover completely
| |
| | available. These vaccines must be
|
| from systemic manifestations, but good
| |
| | administered IM. Pups 6-7 wk old should
|
| nursing care is essential. Despite
| |
| | receive the measles or combination
|
| intensive care, some dogs do not make a
| |
| | vaccine and at least two more doses of
|
| satisfactory recovery. Unfortunately,
| |
| | MLV distemper vaccine when 12-16 wk old.
|
| treatment for neurologic manifestations
| |
| | Many varieties of attenuated distemper
|
| of distemper are unsuccessful. If the
| |
| | vaccine are available and should be used
|
| neurologic signs are progressive or
| |
| | according to manufacturers' directions.
|
| severe, the owner should be appropriately
| |
| | Annual revaccination is suggested because
|
| advised.
| |
| | of the breaks in neurologic distemper
|
| Prevention: Successful immunization of
| |
| | that can occur in stressed, diseased, or
|
| pups with canine distemper modified live
| |
| | immunosuppressed dogsaaheroe is a
|
| virus (MLV) vaccines depends on the lack
| |
| | webmaster and cat and dog lover.
|
